novel transcript, antisense to KALRN (ENSG00000297494)

This entry describes a long non-coding RNA transcript (also termed natural antisense transcript) that is produced from the DNA strand opposite to the KALRN (Kalirin) gene. Antisense transcripts are widespread in the genome and can regulate their associated protein-coding genes by mechanisms such as chromatin modification, transcriptional interference, and RNA:RNA interactions, which may affect the expression levels, processing, or stability of the sense (protein-coding) transcripts[1][3][5]. For KALRN, which encodes a key synaptic Rho-GEF protein involved in neuron structure and neurological disease[4][6], the biological significance of this antisense transcript is unknown. There is no evidence that this antisense transcript is itself a protein, receptor, enzyme, or direct therapeutic target, and the name "novel transcript" is non-standard and does not conform to recognized molecular nomenclature or target conventions. Key points: This transcript is not a protein or receptor and not a drug target. It is named systematically, not canonically; its function is not established. There is no evidence for disease relevance or drug interaction for this antisense RNA. The entry should be considered incorrect as a therapeutic target; most structured drug and molecular databases would not list this as a target.

Other names

novel transcript antisense to KALRNENSG00000297494

Not applicable